Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

06:46 ET Elasmogen anuncia un panel de nuevos candidatos terapéuticos potentes anti-COVID-19

Elasmogen Ltd, compañía biofarmacéutica pionera que lidera el desarrollo de los biológicos VNAR y soloMER™, anunció hoy el descubrimiento...


06:44 ET Israeli Technology Leading World Out of COVID-19 Crisis

The IMPROVATE Innovation Conference held online and in Tel Aviv last week dealt with the day after the global crisis, with Israeli technology and...


06:00 ET NEUVOGEN Appoints Dr. Christian Ottensmeier Head of Scientific Advisory Board

NEUVOGEN, an immunoncology company, is pleased to appoint Christian Ottensmeier MD, PhD, FRCP Head of our Scientific Advisory Board ("SAB")....


04:05 ET Biopharmaceuticals Contract Manufacturing Market Size Worth $25.1 Billion By 2028: Grand View Research, Inc.

The global biopharmaceuticals contract manufacturing market size is expected to reach USD 25.1 billion by 2028 registering a CAGR of 5.7% from 2021...


03:00 ET Quercis Pharma Licenses Key Patents for Thromboembolism Platform Across Cancer and COVID-19 Indications

Quercis Pharma AG, a private, clinical stage biopharmaceutical company leveraging its novel antithrombotic platform, announced that it has entered...


Jan 24, 2021, 19:01 ET Elasmogen annonce la création d'un panel de candidats thérapeutiques novateurs efficaces contre le COVID-19, identifiés en collaboration avec des partenaires de recherche américains

Elasmogen Ltd, l'entreprise biopharmaceutique qui dirige la mise au point de produits biologiques de type VNAR et soloMER™, a annoncé aujourd'hui une ...


Jan 24, 2021, 19:01 ET Elasmogen gibt eine Reihe neuartiger, wirksamer Anti-COVID-19-Therapiekandidaten bekannt, die in Zusammenarbeit mit US-Forschungspartnern identifiziert wurden

Elasmogen Ltd, das bahnbrechende biopharmazeutische Unternehmen, das die Entwicklung der VNAR- und soloMER™-Biologika anführt, gibt heute einen...


Jan 24, 2021, 19:01 ET Elasmogen announces a panel of novel, potent, anti-COVID-19 therapeutic candidates identified through collaboration with U.S. research partners

Elasmogen Ltd, the pioneering biopharmaceutical company leading the development of VNAR and soloMER™ biologics, today announces a significant...


Jan 23, 2021, 12:33 ET Menarini obtient l'approbation de la Commission européenne pour l'utilisation d'ELZONRIS (tagraxofusp) dans le traitement du néoplasme des cellules dendritiques plasmacétoïdes blastiques (NCDPB)

Le groupe Menarini, une société privée italienne de produits pharmaceutiques et de diagnostic, a annoncé aujourd'hui que la Commission européenne lui ...


Jan 23, 2021, 09:22 ET Menarini erhält die Zulassung der Europäischen Kommission für ELZONRIS (Tagraxofusp) zur Behandlung von blastischen plasmazytoiden dendritischen Zellneoplasmen (BPDCN)

Die Menarini Group, ein privates italienisches Pharma- und Diagnostikunternehmen, gab heute bekannt, dass die Europäische Kommission (EC) eine...


Jan 23, 2021, 09:00 ET Prism Health Lab Opens Their 6th Location at the Chinatown Branch of the Chicago Public Library, Enabling Easily Accessible COVID-19 Testing

Prism Health Lab - a branch of the 30+-year-old Prism Group of Companies - has launched its sixth location in as many months in the Chinatown...


Jan 22, 2021, 21:25 ET Lupus Research Alliance Hails Approval of Aurinia's Lupkynis(TM) (voclosporin)

The Lupus Research Alliance (LRA) is excited to share that the U.S. Food and Drug Administration (FDA) approved the use of Aurinia Pharmaceuticals'...


Jan 22, 2021, 21:12 ET Lupus Foundation of America Congratulates Aurinia Pharmaceuticals on FDA Approval of Lupkynis™ (voclosporin) to Treat Lupus Nephritis

For the second time in less than two months, the U.S. Food and Drug Administration (FDA) has approved a new medication to treat adults with lupus...


Jan 22, 2021, 16:15 ET BioLineRx Announces Closing of $34.5 Million Bought Deal Offering and Full Exercise of the Option of the Underwriter

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, today announced the closing of its...


Jan 22, 2021, 15:42 ET Brookdale Hosts 500th Community COVID-19 Vaccination Clinic for Residents and Community Employees

Brookdale Senior Living Inc. hosted a COVID-19 vaccination clinic for its residents and community employees at its 500th community today. The...


Jan 22, 2021, 13:56 ET Menarini recibe la aprobación de la Comisión Europea para ELZONRIS (tagraxofusp) para el tratamiento de la neoplasia blástica plasmocitoide de células dendríticas (BPDCN)

El Grupo Menarini, una empresa italiana farmacéutica y de diagnóstico, de capital privado, anunció hoy que la Comisión Europea (CE) ha otorgado la...


Jan 22, 2021, 10:37 ET Menarini recebe aprovação pela Comissão Europeia de ELZONRIS (tagraxofusp) para o tratamento de neoplasia blástica de células dendríticas plasmocitóides (Blastic Plasmacytoid Dendritic Cell Neoplasm, BPDCN)

O Grupo Menarini, uma empresa privada italiana no setor farmacêutico e de diagnóstico, anunciou hoje que a Comissão Europeia (CE) concedeu uma...


Jan 22, 2021, 09:00 ET Seelos Therapeutics Receives a Notice of Allowance in Japan for SLS-005 (Trehalose)

Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous...


Jan 22, 2021, 08:55 ET Lilly Completes Acquisition of Prevail Therapeutics

Eli Lilly and Company (NYSE:LLY) today announced the successful completion of its acquisition of Prevail Therapeutics Inc. (NASDAQ: PRVL). The...


Jan 22, 2021, 07:30 ET World Autoinjectors Markets Report 2020-2027 Featuring Key Players - Amgen, Antares Pharma, Becton Dickinson and Co, Eli Lilly and Co, J&J, Mylan Novartis SHL Medical Teva Pharma & Ypsomed

The "Autoinjectors Market by Type, Application, and End user: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to...


Jan 22, 2021, 07:16 ET Upadacitinibe Demonstrou Superioridade a Dupilumabe em Todas as Metas, Primárias e Secundárias, em Estudo Comparativo com Pacientes de Dermatite Atópica

A AbbVie (NYSE: ABBV) anunciou os primeiros resultados do estudo de fase 3b Heads Up, que demonstram a superioridade de upadacitinibe (30 mg, uma vez ...


Jan 22, 2021, 01:21 ET Nanoform's Clinical Study Indicates Positive Interim Results

Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, today announced positive interim results from its clinical...


Jan 21, 2021, 23:00 ET Senhwa Announces the First Patient Enrolled in an Investigator Initiated Trial Of Silmitasertib as a Treatment for Patients with Severe COVID-19

Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics...


Jan 21, 2021, 22:57 ET Janssen Announces U.S. FDA Approval of CABENUVA (rilpivirine and cabotegravir), the First Long-Acting Regimen for the Treatment of HIV

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved CABENUVA...


Jan 21, 2021, 17:41 ET Aurora Cannabis Inc. Announces US$125 Million Bought Deal Financing

NYSE | TSX: ACB EDMONTON, AB, Jan. 21, 2021 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE: ACB) (TSX: ACB), the Canadian...